CN108264549A - Recombinate the preparation method and application of chorionic gonadotrophin rhCG - Google Patents
Recombinate the preparation method and application of chorionic gonadotrophin rhCG Download PDFInfo
- Publication number
- CN108264549A CN108264549A CN201810271691.7A CN201810271691A CN108264549A CN 108264549 A CN108264549 A CN 108264549A CN 201810271691 A CN201810271691 A CN 201810271691A CN 108264549 A CN108264549 A CN 108264549A
- Authority
- CN
- China
- Prior art keywords
- rhcg
- fish
- hcg
- amino acid
- recombination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960004407 chorionic gonadotrophin Drugs 0.000 title claims abstract description 23
- 101100468640 Danio rerio rhcgl2 gene Proteins 0.000 title claims abstract description 15
- 101150053759 rhcg gene Proteins 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 title claims description 7
- 102000057593 human F8 Human genes 0.000 title claims description 7
- 229940047431 recombinate Drugs 0.000 title claims description 7
- 235000019688 fish Nutrition 0.000 claims abstract description 75
- 241000251468 Actinopterygii Species 0.000 claims abstract description 71
- 238000005215 recombination Methods 0.000 claims abstract description 35
- 230000006798 recombination Effects 0.000 claims abstract description 34
- 230000032696 parturition Effects 0.000 claims abstract description 26
- 239000013505 freshwater Substances 0.000 claims abstract description 12
- 241000124008 Mammalia Species 0.000 claims abstract description 8
- 238000005411 Van der Waals force Methods 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- 238000002347 injection Methods 0.000 claims description 26
- 239000007924 injection Substances 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 26
- 210000004027 cell Anatomy 0.000 claims description 21
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 241001465754 Metazoa Species 0.000 claims description 14
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 235000013601 eggs Nutrition 0.000 claims description 11
- 238000005457 optimization Methods 0.000 claims description 10
- 239000013604 expression vector Substances 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 7
- 241000276618 Perciformes Species 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 239000013598 vector Substances 0.000 claims description 5
- 108020004705 Codon Proteins 0.000 claims description 4
- 241000252206 Cypriniformes Species 0.000 claims description 4
- 241000276446 Gadiformes Species 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 241000252210 Cyprinidae Species 0.000 claims description 3
- 241001494479 Pecora Species 0.000 claims description 3
- 238000009395 breeding Methods 0.000 claims description 3
- 230000001488 breeding effect Effects 0.000 claims description 3
- 230000012173 estrus Effects 0.000 claims description 3
- 241000972773 Aulopiformes Species 0.000 claims description 2
- 230000008859 change Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 235000019515 salmon Nutrition 0.000 claims description 2
- 210000000130 stem cell Anatomy 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 2
- 241001417105 Clupea pallasii Species 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 210000002700 urine Anatomy 0.000 abstract description 17
- 238000004519 manufacturing process Methods 0.000 abstract description 11
- 239000012535 impurity Substances 0.000 abstract description 3
- 230000004720 fertilization Effects 0.000 description 17
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 12
- 241001597062 Channa argus Species 0.000 description 10
- 241000376029 Tachysurus fulvidraco Species 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 239000013642 negative control Substances 0.000 description 9
- 210000001672 ovary Anatomy 0.000 description 9
- 241000282414 Homo sapiens Species 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 7
- 230000013595 glycosylation Effects 0.000 description 7
- 238000006206 glycosylation reaction Methods 0.000 description 7
- 241000699802 Cricetulus griseus Species 0.000 description 6
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 210000004681 ovum Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 241001275898 Mylopharyngodon piceus Species 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000017448 oviposition Effects 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- ORTYMGHCFWKXHO-UHFFFAOYSA-N diethadione Chemical compound CCC1(CC)COC(=O)NC1=O ORTYMGHCFWKXHO-UHFFFAOYSA-N 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 230000012447 hatching Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 239000012286 potassium permanganate Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 241001417978 Channidae Species 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- SOACHCFYJMCMHC-BWBBJGPYSA-N Ser-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N)O SOACHCFYJMCMHC-BWBBJGPYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 108010060199 cysteinylproline Proteins 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 229960003675 diethadione Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000001323 posttranslational effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 210000002993 trophoblast Anatomy 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 238000012784 weak cation exchange Methods 0.000 description 2
- LGQPPBQRUBVTIF-JBDRJPRFSA-N Ala-Ala-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LGQPPBQRUBVTIF-JBDRJPRFSA-N 0.000 description 1
- NIZKGBJVCMRDKO-KWQFWETISA-N Ala-Gly-Tyr Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 1
- OYJCVIGKMXUVKB-GARJFASQSA-N Ala-Leu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N OYJCVIGKMXUVKB-GARJFASQSA-N 0.000 description 1
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 1
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 1
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical class N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- WKPXXXUSUHAXDE-SRVKXCTJSA-N Arg-Pro-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O WKPXXXUSUHAXDE-SRVKXCTJSA-N 0.000 description 1
- IARGXWMWRFOQPG-GCJQMDKQSA-N Asn-Ala-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IARGXWMWRFOQPG-GCJQMDKQSA-N 0.000 description 1
- JEPNYDRDYNSFIU-QXEWZRGKSA-N Asn-Arg-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(N)=O)C(O)=O JEPNYDRDYNSFIU-QXEWZRGKSA-N 0.000 description 1
- SZNGQSBRHFMZLT-IHRRRGAJSA-N Asn-Pro-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SZNGQSBRHFMZLT-IHRRRGAJSA-N 0.000 description 1
- VHQSGALUSWIYOD-QXEWZRGKSA-N Asn-Pro-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O VHQSGALUSWIYOD-QXEWZRGKSA-N 0.000 description 1
- QQXOYLWJQUPXJU-WHFBIAKZSA-N Asp-Cys-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O QQXOYLWJQUPXJU-WHFBIAKZSA-N 0.000 description 1
- UBPMOJLRVMGTOQ-GARJFASQSA-N Asp-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N)C(=O)O UBPMOJLRVMGTOQ-GARJFASQSA-N 0.000 description 1
- ZKAOJVJQGVUIIU-GUBZILKMSA-N Asp-Pro-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZKAOJVJQGVUIIU-GUBZILKMSA-N 0.000 description 1
- GFYOIYJJMSHLSN-QXEWZRGKSA-N Asp-Val-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GFYOIYJJMSHLSN-QXEWZRGKSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 241001454694 Clupeiformes Species 0.000 description 1
- UKVGHFORADMBEN-GUBZILKMSA-N Cys-Arg-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UKVGHFORADMBEN-GUBZILKMSA-N 0.000 description 1
- QLCPDGRAEJSYQM-LPEHRKFASA-N Cys-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N)C(=O)O QLCPDGRAEJSYQM-LPEHRKFASA-N 0.000 description 1
- UUERSUCTHOZPMG-SRVKXCTJSA-N Cys-Asn-Tyr Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UUERSUCTHOZPMG-SRVKXCTJSA-N 0.000 description 1
- QJUDRFBUWAGUSG-SRVKXCTJSA-N Cys-Cys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)N QJUDRFBUWAGUSG-SRVKXCTJSA-N 0.000 description 1
- YRKJQKATZOTUEN-ACZMJKKPSA-N Cys-Gln-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N YRKJQKATZOTUEN-ACZMJKKPSA-N 0.000 description 1
- XELISBQUZZAPQK-CIUDSAMLSA-N Cys-His-Cys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N XELISBQUZZAPQK-CIUDSAMLSA-N 0.000 description 1
- MRVSLWQRNWEROS-SVSWQMSJSA-N Cys-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CS)N MRVSLWQRNWEROS-SVSWQMSJSA-N 0.000 description 1
- KVGPYKUIHZJWGA-BQBZGAKWSA-N Cys-Met-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O KVGPYKUIHZJWGA-BQBZGAKWSA-N 0.000 description 1
- TXGDWPBLUFQODU-XGEHTFHBSA-N Cys-Pro-Thr Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O TXGDWPBLUFQODU-XGEHTFHBSA-N 0.000 description 1
- XBELMDARIGXDKY-GUBZILKMSA-N Cys-Pro-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)N XBELMDARIGXDKY-GUBZILKMSA-N 0.000 description 1
- FCXJJTRGVAZDER-FXQIFTODSA-N Cys-Val-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O FCXJJTRGVAZDER-FXQIFTODSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- KYFSMWLWHYZRNW-ACZMJKKPSA-N Gln-Asp-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N KYFSMWLWHYZRNW-ACZMJKKPSA-N 0.000 description 1
- JNENSVNAUWONEZ-GUBZILKMSA-N Gln-Lys-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O JNENSVNAUWONEZ-GUBZILKMSA-N 0.000 description 1
- SOEXCCGNHQBFPV-DLOVCJGASA-N Gln-Val-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SOEXCCGNHQBFPV-DLOVCJGASA-N 0.000 description 1
- UENPHLAAKDPZQY-XKBZYTNZSA-N Glu-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)N)O UENPHLAAKDPZQY-XKBZYTNZSA-N 0.000 description 1
- SYWCGQOIIARSIX-SRVKXCTJSA-N Glu-Pro-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O SYWCGQOIIARSIX-SRVKXCTJSA-N 0.000 description 1
- YLEIWGJJBFBFHC-KBPBESRZSA-N Gly-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 YLEIWGJJBFBFHC-KBPBESRZSA-N 0.000 description 1
- GAAHQHNCMIAYEX-UWVGGRQHSA-N Gly-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GAAHQHNCMIAYEX-UWVGGRQHSA-N 0.000 description 1
- WSWWTQYHFCBKBT-DVJZZOLTSA-N Gly-Thr-Trp Chemical compound C[C@@H](O)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O WSWWTQYHFCBKBT-DVJZZOLTSA-N 0.000 description 1
- KAXZXLSXFWSNNZ-XVYDVKMFSA-N His-Ser-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KAXZXLSXFWSNNZ-XVYDVKMFSA-N 0.000 description 1
- BRQKGRLDDDQWQJ-MBLNEYKQSA-N His-Thr-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O BRQKGRLDDDQWQJ-MBLNEYKQSA-N 0.000 description 1
- FFYYUUWROYYKFY-IHRRRGAJSA-N His-Val-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O FFYYUUWROYYKFY-IHRRRGAJSA-N 0.000 description 1
- 241000720946 Hypophthalmichthys molitrix Species 0.000 description 1
- WECYRWOMWSCWNX-XUXIUFHCSA-N Ile-Arg-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O WECYRWOMWSCWNX-XUXIUFHCSA-N 0.000 description 1
- YGDWPQCLFJNMOL-MNXVOIDGSA-N Ile-Leu-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YGDWPQCLFJNMOL-MNXVOIDGSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 1
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 1
- UCOCBWDBHCUPQP-DCAQKATOSA-N Leu-Arg-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O UCOCBWDBHCUPQP-DCAQKATOSA-N 0.000 description 1
- ZTLGVASZOIKNIX-DCAQKATOSA-N Leu-Gln-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZTLGVASZOIKNIX-DCAQKATOSA-N 0.000 description 1
- DPWGZWUMUUJQDT-IUCAKERBSA-N Leu-Gln-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O DPWGZWUMUUJQDT-IUCAKERBSA-N 0.000 description 1
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 1
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 1
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 description 1
- GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 1
- PLDJDCJLRCYPJB-VOAKCMCISA-N Lys-Lys-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PLDJDCJLRCYPJB-VOAKCMCISA-N 0.000 description 1
- YRNRVKTYDSLKMD-KKUMJFAQSA-N Lys-Ser-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YRNRVKTYDSLKMD-KKUMJFAQSA-N 0.000 description 1
- PNDCUTDWYVKBHX-IHRRRGAJSA-N Met-Asp-Tyr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PNDCUTDWYVKBHX-IHRRRGAJSA-N 0.000 description 1
- USBFEVBHEQBWDD-AVGNSLFASA-N Met-Leu-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O USBFEVBHEQBWDD-AVGNSLFASA-N 0.000 description 1
- KSIPKXNIQOWMIC-RCWTZXSCSA-N Met-Thr-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KSIPKXNIQOWMIC-RCWTZXSCSA-N 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 241001405332 Ophiocephalus Species 0.000 description 1
- 108010072194 Ovidrel Proteins 0.000 description 1
- SXJGROGVINAYSH-AVGNSLFASA-N Phe-Gln-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N SXJGROGVINAYSH-AVGNSLFASA-N 0.000 description 1
- JWQWPTLEOFNCGX-AVGNSLFASA-N Phe-Glu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JWQWPTLEOFNCGX-AVGNSLFASA-N 0.000 description 1
- INHMISZWLJZQGH-ULQDDVLXSA-N Phe-Leu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 INHMISZWLJZQGH-ULQDDVLXSA-N 0.000 description 1
- HBXAOEBRGLCLIW-AVGNSLFASA-N Phe-Ser-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N HBXAOEBRGLCLIW-AVGNSLFASA-N 0.000 description 1
- BNBBNGZZKQUWCD-IUCAKERBSA-N Pro-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H]1CCCN1 BNBBNGZZKQUWCD-IUCAKERBSA-N 0.000 description 1
- XUSDDSLCRPUKLP-QXEWZRGKSA-N Pro-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 XUSDDSLCRPUKLP-QXEWZRGKSA-N 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- QNZLIVROMORQFH-BQBZGAKWSA-N Pro-Gly-Cys Chemical compound C1C[C@H](NC1)C(=O)NCC(=O)N[C@@H](CS)C(=O)O QNZLIVROMORQFH-BQBZGAKWSA-N 0.000 description 1
- VZKBJNBZMZHKRC-XUXIUFHCSA-N Pro-Ile-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O VZKBJNBZMZHKRC-XUXIUFHCSA-N 0.000 description 1
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 description 1
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 1
- GMJDSFYVTAMIBF-FXQIFTODSA-N Pro-Ser-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GMJDSFYVTAMIBF-FXQIFTODSA-N 0.000 description 1
- 241000700141 Rotifera Species 0.000 description 1
- GXXTUIUYTWGPMV-FXQIFTODSA-N Ser-Arg-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O GXXTUIUYTWGPMV-FXQIFTODSA-N 0.000 description 1
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 1
- VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 description 1
- 241001471302 Tachysurus Species 0.000 description 1
- KZUJCMPVNXOBAF-LKXGYXEUSA-N Thr-Cys-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O KZUJCMPVNXOBAF-LKXGYXEUSA-N 0.000 description 1
- DDDLIMCZFKOERC-SVSWQMSJSA-N Thr-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N DDDLIMCZFKOERC-SVSWQMSJSA-N 0.000 description 1
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 1
- SBYQHZCMVSPQCS-RCWTZXSCSA-N Thr-Val-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O SBYQHZCMVSPQCS-RCWTZXSCSA-N 0.000 description 1
- GFZQWWDXJVGEMW-ULQDDVLXSA-N Tyr-Arg-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GFZQWWDXJVGEMW-ULQDDVLXSA-N 0.000 description 1
- WVGKPKDWYQXWLU-BZSNNMDCSA-N Tyr-His-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CCCCN)C(=O)O)N)O WVGKPKDWYQXWLU-BZSNNMDCSA-N 0.000 description 1
- XGZBEGGGAUQBMB-KJEVXHAQSA-N Tyr-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=C(C=C2)O)N)O XGZBEGGGAUQBMB-KJEVXHAQSA-N 0.000 description 1
- PVPAOIGJYHVWBT-KKHAAJSZSA-N Val-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N)O PVPAOIGJYHVWBT-KKHAAJSZSA-N 0.000 description 1
- CVIXTAITYJQMPE-LAEOZQHASA-N Val-Glu-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CVIXTAITYJQMPE-LAEOZQHASA-N 0.000 description 1
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 1
- HJSLDXZAZGFPDK-ULQDDVLXSA-N Val-Phe-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N HJSLDXZAZGFPDK-ULQDDVLXSA-N 0.000 description 1
- HWNYVQMOLCYHEA-IHRRRGAJSA-N Val-Ser-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N HWNYVQMOLCYHEA-IHRRRGAJSA-N 0.000 description 1
- OFTXTCGQJXTNQS-XGEHTFHBSA-N Val-Thr-Ser Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N)O OFTXTCGQJXTNQS-XGEHTFHBSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 239000012297 crystallization seed Substances 0.000 description 1
- 108010004073 cysteinylcysteine Proteins 0.000 description 1
- 108010069495 cysteinyltyrosine Proteins 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000011118 depth filtration Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 230000026109 gonad development Effects 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 229940112876 ovidrel Drugs 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 230000006320 pegylation Effects 0.000 description 1
- 108010064486 phenylalanyl-leucyl-valine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108010025826 prolyl-leucyl-arginine Proteins 0.000 description 1
- 230000020978 protein processing Effects 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- WESJNFANGQJVKA-UHFFFAOYSA-M sodium;2,3-dichloro-2-methylpropanoate Chemical compound [Na+].ClCC(Cl)(C)C([O-])=O WESJNFANGQJVKA-UHFFFAOYSA-M 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/10—Culture of aquatic animals of fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Marine Sciences & Fisheries (AREA)
- Plant Pathology (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to the preparation methods of recombination chorionic gonadotrophin rhCG, and recombination chorionic gonadotrophin rhCG is expressed using mammal eukaryotic expression system;The recombination chorionic gonadotrophin rhCG includes α and β subunits, and the two is connected by Van der Waals force.The recombination chorionic gonadotrophin rhCG of the present invention hastens parturition for fish, and, purity higher more more stable than the urine source hCG mass of production at present, impurity are less, and spawning effect is more preferable, applications of the alternative urine source hCG in fish reproduction.The invention further relates to applications of the recombination hCG in fresh-water fishes artificial propagation field.
Description
Technical field
The present invention relates to biological medicine and technical field of animal reproduction, specifically, being related to recombinating chorionic gonadotrophin rhCG's
Preparation method and application.
Background technology
Fish reproduction and residing ecological environment are closely related, under normal circumstances, ecological factor, such as nutrition, temperature, light
It is the determinant of fish gonad development according to, flow etc..However under the conditions of artificial propagation, shortage rivers have comprehensive in pond
Ecological condition (flow velocity of such as water, the cataclysm of water level etc.) is closed, some chinese carp sexual glands cannot reach maturity, such as black carp parent population sexual gland one
As be extremely difficult to for IV end of term;Even if the chinese carp of gonadal maturation can not voluntarily ovulate in pond, palpus manual injection hastens parturition
Agent can ovulate fertilization.The purpose of manual injection's ocyodinic is:On the one hand prevent certain sexual glands under artificial condition from voluntarily into
Ripe fish (such as black carp) reach maturity with row's essence of laying eggs;On the other hand also promote the fish that can lay eggs smart concentration same period ovulation
Production essence is convenient for unified breeding management.
It hastens parturition in due course, reasonable employment ocyodinic is most important to fish reproduction.The upper common ocyodinic of production at present is main
There are artificial synthetic analogues (LRH-A), fish brain hypophysis (PG), human chorionic gonadotrophin (chorionic gonadotrophin, hCG) and dioxone
(DOM).Different types of parent population is very big to the sensitivity differences of different ocyodinics, needs selection quick to the parent population in practical applications
Several ocyodinics are used cooperatively by the ocyodinic of sense, and effect is better than single ocyodinic.
HCG is a kind of glycoprotein hormones secreted by Human plactnta syncytiotrophoblast, including two non-covalent bonds of α and β
With reference to subunit.HCG promotes the formation reached maturity with corpus luteum of female egg mother cell, promotes the life of male creature sperm
Into.HCG is clinically usually used in assisted reproductive therapy in people doctor, and treatment is infertile.HCG is usually used in animal reproduction production
Pig, ox, the estrus synchronization of sheep and superfecundation.The artificial repening that hCG is mainly used for fish in terms of fish reproduction hastens parturition, ovulates
Production essence, is one of preferred ocyodinic of artificial propagation of fish.
The commercialization hCG mainly extraction purifications from urine of pregnant women at present, but large scale collection urine of pregnant women difficulty it is big, into
This height, the hCG product batches differences purified are big, and there are the security risks that urine donor is brought.In addition hCG to light,
The conditions such as temperature and acidity are extremely sensitive, if the urine of collection is extracted not in time, it is easy to lose biological activity, cause resource
Waste.Therefore, people have utilized technique for gene engineering exploitation novel human recombination hCG products, such as Merck Xue Lannuo
Ovidrel (recombination physex parenteral solution), the injection chorionic gonadotrophin (beautiful pearl is currently urine source hCG) of beautiful pearl, recombinate hCG
Product quality is relatively uniform, purity is high, impurity is few, safety coefficient is big, gradually replaces people's urine source hCG products.
The common expression system of recombinant protein mainly has at present:Escherichia coli, yeast, insect cell and mammal are thin
Born of the same parents.Each expression system has respective advantage and deficiency, need to be according to the characteristics of destination protein and expression system, and it is suitable to select
Expression system.Escherichia expression system production cost is low, yield is high, expression flow is simple and quick, but is turned over due to a lack of protein
Processing mechanism after translating, such as glycosylation, correct folding etc. are not suitable for expression complexity and most animals cell protein.Yeast table
The advantages of having protokaryon and Higher eukaryotic expression system concurrently up to system, the albumen of harvest have certain post translational processing ability, but
It is that there are still deficiencies, such as easily forms protein multimers and excessive glycosylation, therefore be more suitable for expressing simple eucaryote egg
In vain.Insect expression system can express higher eucaryote albumen, and albumen can be carried out correctly to fold and modify, but protein content
It is low, it is difficult to form seed lot.Mammalian cell expression system albumen can be carried out it is correct fold and complicated glycosylation modified,
It is suitble to the complicated higher eucaryote albumen of expression;But expression flow is complicated, the period is long, and cost is higher.In practical applications, should
According to different expression requirements, suitable expression system and strategy are selected.HCG is a kind of by Human plactnta syncytiotrophoblast point
The glycoprotein hormones secreted, the subunit combined including two non-covalent bonds of α and β.Theoretically with mammalian cell come Expression product
Reproductive hormone albumen, space structure and the closer natural products of glycosylation, it is ensured that its physiological activity.
The dynamic hCG for protecting sector application is still mainly extracted from pregnant woman urine at present, there is no the related report of recombination hCG products
Road.
Invention content
The object of the present invention is to provide the preparation methods of recombination chorionic gonadotrophin rhCG.
It is a further object of the present invention to provide the applications of recombination chorionic gonadotrophin rhCG.
Another object of the present invention is to provide a kind of method that fish are hastened parturition.
The design of the present invention is as follows:Recombination hCG products, and quality phase can be obtained on a large scale using gene recombination technology
To it is uniform, purity is high, impurity is few, safety coefficient is big.Mammalian cell expression system, can compared with other expression systems
It obtains in terms of molecular structure, physicochemical property and biological function closest to natural higher organism protein molecular.
In order to realize the object of the invention, the present invention provides the preparation method of recombination chorionic gonadotrophin rhCG, utilizes mammal
Eukaryotic expression system expression recombination chorionic gonadotrophin rhCG;The recombination chorionic gonadotrophin rhCG includes α and β subunits, and the two passes through model
De Huali connections.
Wherein, the α subunits:
I) by SEQ ID NO:The albumen that amino acid sequence shown in 1 is formed;Or
ii)SEQ ID NO:Amino acid sequence shown in 1 is substituted, lacks and ors add one or several amino acid and same
Etc. functions the albumen as derived from i);Or
Iii) with SEQ ID NO:Amino acid sequence homology shown in 1 is more than 90%, and the ammonia with equal function
The albumen that base acid sequence is formed.
The β subunits:
I) by SEQ ID NO:The albumen that amino acid sequence shown in 3 is formed;Or
ii)SEQ ID NO:Amino acid sequence shown in 3 is substituted, lacks and ors add one or several amino acid and same
Etc. functions the albumen as derived from i);Or
Iii) with SEQ ID NO:Amino acid sequence homology shown in 3 is more than 90%, and the ammonia with equal function
The albumen that base acid sequence is formed.
Aforementioned method according to the gene order of NCBI hCG α and the β subunits announced, is had a preference for according to mammalian codons
Property carry out gene order optimization, the gene order of the α and β subunits after optimization is implemented in different expression cassettes, then connects respectively
Onto same expression vector, host cell is converted, and expressed in host cell, isolate and purify target protein;Alternatively,
The gene order of α and β subunits after optimization is building up on expression vector respectively, gained recombinant vector cotransformation place
Chief cell, and expressed in host cell, isolate and purify target protein.
In the present invention, the gene order of the α and β subunits after optimization is respectively such as SEQ ID NO:Shown in 2 and 4.
Aforementioned method, the expression vector are selected from pCG, pcDNA3.1, pMS2-GFP, pCMV5, preferably pcDNA3.1.
Aforementioned method, the host cell CHO or 293 cells.Wherein, Chinese hamster ovary cell (CHO) is by the U.S.
FDA is confirmed as safe genetic engineering recipient cell, is one of large-scale production most common expression cell of Medicines, preferably
Chinese hamster ovary celI.Chinese hamster ovary celI genetic background understands that physiological metabolism is stablized, and expression is relatively high, shearing force is resistant to, convenient for advising greatly
Mould culture is one of most common expression system of current recombinant protein.
The recombinant vector of above-mentioned hCG α and the β subunits containing recombination is gone in host expression system, mammalian expression systems
Albumen can be instructed correctly to fold, complicated N-type glycosylation and accurately a variety of post translational processing work(such as O-shaped glycosylation are provided
Can, it can obtain in terms of molecular structure, physicochemical property and biological function closest to natural protein molecular.
The present invention also provides prepare according to the method described above recombination chorionic gonadotrophin rhCG (and its derived protein or by modification
Albumen) following any application:
1) promote the application in animal reproduction;
2) application in the medicine preparation for the treatment of animals' reproduction relevant disease;
3) application in ocyodinic is prepared.
By the albumen of modification, combined including the rhCG through glycosylation, Pegylation, acetylation or with BSA,
It belongs to the scope of protection of the present invention.
By the albumen of transformation, do not change the rhCG protein actives including what the rhCG and other protein fusions were formed
Fusion protein, all belong to the scope of protection of the present invention.
Aforementioned application, the animal are mammal or fish;Wherein, the mammal is the economy such as pig, ox, sheep
Animal, family's pack animal or dog.
In the present invention, the fish include fresh water or marine fishes, preferably freshwater fish, including four large Chinese carps (black carp, grass
Fish, silver carp and bighead) and the economic fish such as Cypriniformes, Perciformes, Silurformes, salmon shape mesh, Gadiformes, Clupeiformes, Gadiformes, more
It is preferred that Cypriniformes, Perciformes, Silurformes economic fish.For example, the fresh-water fishes such as silver carp, snakehead, Pelteobagrus fulvidraco, black carp.
The promotion animal reproduction refers to promote oocyte maturation, promotion estrus synchronization, superfecundation, induced breeding
Deng.It hastens parturition especially suitable for fish.
The present invention also provides a kind of fish ocyodinic, at least contain the rhCG in active constituent.In addition, also it may include
LRH-A (such as LRH-A2、LRH-A3), fish brain hypophysis (PG), the ingredients such as dioxone (DOM).
The present invention also provides the methods that fish are hastened parturition, and are hastened parturition by injecting above-mentioned ocyodinic to fish.
Aforementioned method, the injection dosage of rhCG is 200-2000IU/kg weight.For the injection of freshwater fish rhCG
It measures as 200-2000IU/kg weight.
Preferably, it is hastened parturition using two needle injections, the ocyodinic injected for the first time is LRH-A, and injection dosage is 1-2 μ g/kg
Weight;It injects for the first time and carries out second after 10-12h and inject, the ocyodinic of second of injection is LRH-A2-10 μ g/kg weight,
DOM 5-6 μ g/kg weight and rhCG 400-600IU/kg weight.
For the silver carp parent population of 5kg or so, induced spawning method is as follows:LRH-A is injected for the first time2, dosage is 1 μ g/kg weight;It is first
Second is carried out after secondary injection 12h to inject, and injects LRH-A for the second time25 μ g/kg weight, 5 μ g/kg weight of DOM and rhCG
500IU/kg weight.
For the snakehead parent population of 1.5kg or so, induced spawning method is as follows:LRH-A is injected for the first time3, dosage is 2 μ g/kg weight;
Second of injection is carried out after injecting 12h for the first time, injects LRH-A for the second time32 μ g/kg weight, 5 μ g/kg weight of DOM and rhCG
400IU/kg weight.
For the Pelteobagrus fulvidraco parent population of raun 100g or so, milter 200g or so, induced spawning method is as follows:LRH- is injected for the first time
A3, dosage is 1 μ g/kg weight;Second of injection is carried out after injecting 10h for the first time, injects LRH-A for the second time310 μ g/kg weight,
5 μ g/kg weight of DOM and rhCG 600IU/kg weight.
By above-mentioned technical proposal, the present invention at least has following advantages and advantageous effect:
(1) fish provided by the invention recombination hCG and its derived protein or the albumen by modification is thin in mammal
High efficient expression in born of the same parents-Chinese hamster ovary celI, quality is relatively uniform, and rhCG purity of protein after purification is up to 93%, and purity is high, safety coefficient
Greatly;It is active high, than living up to 14300IU/mg.
(2) fish provided by the invention recombination hCG and its derived protein or the albumen by modification, can effectively improve
Spawning effect to the silver carp for urinating source hCG sensitivities, with reference to ocyodinic LRH-A2With DOM use, the spawning rate of silver carp parent population and by
Smart rate is up to 95% and 96.7%, higher than the 80% and 85.6% of urine source hCG products.
(3) fish provided by the invention recombination hCG and its derived protein or the albumen by modification, to urine source hCG not
Sensitive perciform fishes have good spawning effect, with reference to ocyodinic LRH-A3It is used with DOM, improves the oviposition of snakehead parent population
Rate and rate of fertilization, reduce Effect time, and spawning rate and rate of fertilization (being respectively 95% and 96.3%) are above urine source hCG products
(being respectively 75% and 87.3%).
(4) fish provided by the invention recombination hCG and its derived protein or the albumen by modification, to there is no at present
The Silurformes fish that effect ocyodinic is hastened parturition also have good spawning effect, with reference to ocyodinic LRH-A3It is used with DOM, yellow forehead can be made
The spawning rate and rate of fertilization of fish are improved to 90% and 85.7%, and being above urine source hCG products, (spawning rate and rate of fertilization are respectively
65% and 71.2%).
(5) fish provided by the invention recombination hCG and its derived protein or the albumen by modification, to freshwater fish
Spawning effect is higher than urine source hCG products, can replace application of the urine source hCG products in freshwater fish is hastened parturition.
Description of the drawings
Fig. 1 is the SDS-PAGE electrophoresis that fish recombinates hCG in the embodiment of the present invention 2.Wherein left figure is non-reduced electrophoresis
Figure, right figure are reduction electrophoretogram;MK:Albumen Marker;1:Clarified broth;2:CM FF collection liquids;3:Phenyl collection liquids;
4:QFF collection liquids.
Fig. 2 is the non-reduced electrophoretograms of SDS-PAGE that fish recombinates hCG and uhCG in the embodiment of the present invention 2.MK:Albumen
Marker;1:Recombinate hCG;2:UhCG.
Specific embodiment
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..Unless otherwise specified, embodiment
According to conventional laboratory conditions, as Sambrook equimoleculars Cloning: A Laboratory Manual (Sambrook J&Russell DW,
Molecular Cloning:A Laboratory Manual, 2001) or the condition according to manufacturer's specification suggestion.
Embodiment 4-6 chooses silver carp, snakehead, Pelteobagrus fulvidraco parent population and carries out experiment of hastening parturition respectively, in the first tenday period of a month in May in Guangdong fishing ground
It carries out.
Embodiment 1 recombinates the screening of hCG protein expression systems
HCG is investigated in Escherichia coli (Escherichia coli)-BL21 (DE3), P. pastoris cell
The expression of (Pichia pastoris)-GS115 and mammalian cell-Chinese hamster ovary cell (CHO).In gene
The nucleotide sequence of hCG α (GenBank NM_000735.3) and hCG β (GenBank NM_000737.3) subunit is retrieved in library
It is and artificial synthesized.The nucleotide sequence of hCG α subunits and β subunits is transferred to respectively expression vector pET-28a, pPIC9K and
In pcDNA3.1.The recombinant vector containing α subunits and β subunits is transferred in BL21 (DE3), GS115 and Chinese hamster ovary celI respectively.
BL21 (DE3) does not obtain soluble recombination hCG albumen;Recombination hCG polymers are obtained in GS115 cells, and activity is very low;CHO
Active recombination hCG is obtained in cell, but protein content is low, need to optimize.Final choice Chinese hamster ovary celI is as recombination hCG
Expression system, and the expression system is optimized.
Embodiment 2 recombinates expression and purifying of the hCG albumen in Chinese hamster ovary celI
The nucleotide sequence of hCG α and β subunits that will be retrieved in embodiment 1, according to mammalian codons preferences into
Row codon optimization, α subunits nucleotide sequence such as SEQ ID NO after optimization:Shown in 2, β subunits nucleotide sequence such as SEQ ID
NO:Shown in 4.
The nucleotide sequence of artificial synthesized hCG α subunits and β subunits is transferred to respectively in expression vector pcDNA3.1, it will
Expression recombination hCG in Chinese hamster ovary celI is transferred to after recombinant vector linearisation together.
The steady cell that turns is subjected to fermented and cultured in fermentation tank, zymotic fluid is by two-stage in-depth filtration film packet removal cell and carefully
Born of the same parents' fragment then with 0.22 μm of membrane filtration, obtains clear zymotic fluid.Clear zymotic fluid uses weak cation exchange layer first
Analyse (such as CM FF, GE Healthcare) purifying:Loading is balanced with equilibrium liquid (20mM ammonium acetates, pH5.0), then uses eluent
Eluent is collected in (50Mm PB, 3M sodium chloride, pH8.5) elution.Secondly weak cation exchange is chromatographed into collection liquid hydrophobic layer
Analyse (such as Phenyl, GE Healthcare) purifying:Loading is balanced with equilibrium liquid (50mM PB, 3M sodium chloride, pH8.5), then
It eluted with eluent (10mM PB, pH8.5), collect eluent.Finally hydrophobic chromatography collection liquid is exchanged (such as with strong anion
QFF, GE Healthcare) chromatography be further purified:Loading is balanced with equilibrium liquid (50mM PB, pH8.5), then uses eluent
(50Mm PB, 3M sodium chloride, pH8.5) is eluted, and is collected.PAGE gel electrophoresis is carried out to the recombination hCG (rhCG) of purifying
(Fig. 1);RhCG and urine source hCG carries out PAGE gel electrophoresis (Fig. 2) after purification.
Embodiment 3 recombinates the Activity determination of hCG albumen
By measuring effects of the rhCG to underage mouse uterus weight, the activity of recombination hCG is determined.With reference to Chinese veterinary drug
Pharmacopeia " chorionic gonadotrophin biologic assay ", method is as follows:By hCG standard items and recombination hCG samples, (estimating activity is respectively
15000IU/mg) it is configured to high, medium and low three dosage of 0.625IU/ml, 0.375IU/ml, 0.225IU/ml.Health is chosen to close
Lattice, birth 17-23 day, weight 9-13g, same source female immature mouse, be randomly divided into 6 groups, every group 15 by weight.Daily
Give the standard items or recombination hCG 0.2ml per sub-cutaneous injections respective concentration respectively in the roughly the same time, once a day, continuously
Animal in last time injection is put to death, weighed, dissected, extracted uterus, remove the tissue of attachment, go by injection 3 times afterwards for 24 hours
Except ovary, intrauterine liquid is pressed dry, the uterus weight of every 10g weight is directly weighed and be converted into, according to the quantitative response in biologic assay
It is 14300IU/mg that parallel line assay method, which calculates recombination hCG potency, is urine source hCG (uhCG) potency as defined in veterinary drug allusion quotation
3.2 times of 4500IU/mg.
Embodiment 4 recombinates application of the hCG albumen in silver carp is promoted to hasten parturition
Silver carp, also known as Hypophthalmichthys molitrix, Cypriniformes Cyprinidae silver carp category fish are one of four large Chinese carps of China, the excellent fish more preferably cultivated
One of kind.Property it is active, be apt to jump, the zooplankters such as phytoplanktons and wheel animalcule such as staple food diatom, green algae.
Weight 5kg or so is selected, the silver carp parent population physical strong, disease-free and injury-free, constitution is plentiful is randomly divided into 4 groups:It is negative
Control group, uhCG (uhCG) group, rhCG-1 groups and rhCG-2 groups, every group of 10 tail raun, 5 tail milter.Nurturing period adds throwing appropriate
Fine fodder, increases bath number before hastening parturition, during 25 DEG C of water temperature, hastened parturition using two needle injections, phase is injected according to following table time and dosage
Drug is answered, wherein milter injection halves, and after second is injected, records Effect time.The male and female parent population of heat is manually done
Method is inseminated, and method is as follows:Fish body is dried, the ovum for waiting to produce female parent population is squeezed into basin, squeezes into milter sperm at once, it is light with hand
Light stirring makes smart ovum fully combine and improves rate of fertilization.Being denoted as not laying eggs in raun 6h is not produced, and oviposition is denoted as half on a small quantity in 6h
Production.Parent population after hastening parturition cleans injury with 20ppm potassium permanganate, injects the penicillin anti-inflammatory of 30,000/tail.Fertilized eggs are placed in hatching
Artificial incubation is carried out in circuit, rate of fertilization is calculated after 12h.
The results are shown in Table 1, and silver carp individually injects the spawning rate of rhCG silver carp parent populations and rate of fertilization difference to hCG sensitivities
It for 65% and 77.3%, but is shared with LRH-A and DOM, spawning effect is more excellent, wherein the female fish parent fish Effect time of rhCG-1 groups
(7h) is equal with uhCG groups (7h) raun, is below negative control group (8.5h) and rhCG-2 groups (8h).9 tail raun of rhCG-1 groups
Full production, 1 tail half produce, and spawning rate reaches 95%, rate of fertilization 96.7%, be above negative control group (55% and 67.2%),
UhCG groups (80% and 85.6%) and rhCG-2 groups.
Embodiment 5 recombinates application of the hCG albumen in snakehead is promoted to hasten parturition
Snakehead is commonly called as snakeheaded fish, and Perciformes murrel section Ophiocephalus fish, meat is fine and smooth, meat flavour is delicious, and growth is fast, yield is high, cultivation
Density is high, high efficiency, is a kind of higher rare economic fish of economic value.Property it is violent, be food with fish, shrimp etc..
Select 1.5kg or so, it is disease-free, physical strong, fish body is smooth, the intact snakehead parent population of scale, it is randomly divided into 4
Group:Negative control group, uhCG (uhCG) group, rhCG-1 groups and rhCG-2 groups, every group of 10 tail raun, 5 tail milter.It is fed before hastening parturition
The fresh food of snakehead eating, such as shrimp, tadpole, wild fishes are often washed by water, and during 25 DEG C of water temperature, are hastened parturition using two needle injections,
According to following table time and dosage injection relative medicine, wherein milter injection halves, and after second is injected, records Effect time,
The artificial dry method of the male and female parent population of heat is inseminated, method is as follows:Fish body is dried, the ovum for waiting to produce female parent population is squeezed into basin,
Milter sperm is squeezed at once, is gently mixed with hand, smart ovum is made fully to combine and improves rate of fertilization.What is do not laid eggs in raun 6h is denoted as not
It produces, oviposition is denoted as half production on a small quantity in 6h.Parent population after hastening parturition cleans injury with 20ppm potassium permanganate, injects 30,000/tail mould
Plain anti-inflammatory.Fertilized eggs, which are placed in circular hatching channal, carries out artificial incubation, and rate of fertilization is calculated after 12h.
The results are shown in Table 2, and the Effect time for individually injecting the female fish parent fish of rhCG snakeheads is 26h, spawning rate and rate of fertilization
Respectively 50% and 63.5%, snakehead is insensitive to hCG.RhCG and LRH-A and DOM, which is shared, shows the spawning effect of snakehead parent population
Write, the female fish parent fish Effect time (21h) of rhCG-1 group snakeheads far below negative control group (25h), uhCG groups (22.5h) and
RhCG-2 groups.Female 9 tail of fish parent fish of 10 tail of rhCG-1 groups produces entirely, and 1 tail half produces, and spawning rate reaches 95%, rate of fertilization 96.3%,
Higher than negative control group (70% and 78.4%), uhCG groups (75% and 87.3%) and rhCG-2 groups.
Embodiment 6 recombinates application of the hCG albumen in Pelteobagrus fulvidraco is promoted to hasten parturition
Pelteobagrus fulvidraco, is commonly called as Huang Lading, Silurformes, Pelteobagrus, is a kind of omnivorous biased physical property economic fish, fine and tender taste
Delicious, full of nutrition, the market price is high, is a kind of emerging freshwater aquiculture kind.
Selection raun 100g, milter 200g or so, the Pelteobagrus fulvidraco parent population physical strong, disease-free and injury-free, constitution is plentiful, at random
It is divided into 4 groups:Negative control group, uhCG (uhCG) group, rhCG-1 groups and rhCG-2 groups, every group of 10 tail raun, 5 tail milter.It cultivates
Period, which adds, feeds the bait such as spiral shell freshwater mussel, during 25 DEG C of water temperature, is hastened parturition using two needle injections, corresponding medicine is injected according to following table time and dosage
The injection of object, wherein milter halves, and after second is injected, records Effect time, the artificial dry method of female fish parent fish of heat is awarded
Essence, method are as follows:First gametocide fish takes out spermary, is placed in mortar and shreds, and it is spare to add in spermatozoa preservative fluid.It checks raun, will treat
The ovum of the female parent population of production is squeezed into basin, and sperm and ovum are mixed fertilization with feather.Being denoted as not laying eggs in raun 6h is not produced,
Oviposition is denoted as half production on a small quantity in 6h.Parent population after hastening parturition cleans injury with 20ppm potassium permanganate, and injection 30,000/tail penicillin disappears
It is scorching.Fertilized eggs are placed in hatching road and are hatched, rate of fertilization is calculated after 12h.
As a result as shown in table 3 below, Pelteobagrus fulvidraco is insensitive to various ocyodinics, individually injects the effect of rhCG Pelteobagrus fulvidraco parent populations
It is 23.5h between seasonable, spawning rate and rate of fertilization are respectively 40% and 61.8%.RhCG and LRH-A and DOM is shared to Pelteobagrus fulvidraco parent
The spawning effect of fish is notable.The female fish parent fish Effect time (21.5h) of rhCG-1 group Pelteobagrus fulvidracos less than negative control group (for 24 hours),
UhCG groups (22.5h) and rhCG-2 groups, female 8 tail of fish parent fish of 10 tails produce entirely, and 2 tails half produce, and spawning rate and rate of fertilization are 90% He
85.7%, it is above negative control group (35% and 63.4%), uhCG groups (65% and 71.2%) and rhCG-2 groups.
Although above the present invention is described in detail with a general description of the specific embodiments,
On the basis of the present invention, it can be modified or improved, this will be apparent to those skilled in the art.Cause
This, these modifications or improvements, belong to the scope of protection of present invention without departing from theon the basis of the spirit of the present invention.
Sequence table
<110>Beijing Wei Jiexin bio tech ltd
<120>Recombinate the preparation method and application of chorionic gonadotrophin rhCG
<130> KHP181111214.0
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 116
<212> PRT
<213>People (Homo sapiens)
<400> 1
Met Asp Tyr Tyr Arg Lys Tyr Ala Ala Ile Phe Leu Val Thr Leu Ser
1 5 10 15
Val Phe Leu His Val Leu His Ser Ala Pro Asp Val Gln Asp Cys Pro
20 25 30
Glu Cys Thr Leu Gln Glu Asn Pro Phe Phe Ser Gln Pro Gly Ala Pro
35 40 45
Ile Leu Gln Cys Met Gly Cys Cys Phe Ser Arg Ala Tyr Pro Thr Pro
50 55 60
Leu Arg Ser Lys Lys Thr Met Leu Val Gln Lys Asn Val Thr Ser Glu
65 70 75 80
Ser Thr Cys Cys Val Ala Lys Ser Tyr Asn Arg Val Thr Val Met Gly
85 90 95
Gly Phe Lys Val Glu Asn His Thr Ala Cys His Cys Ser Thr Cys Tyr
100 105 110
Tyr His Lys Ser
115
<210> 2
<211> 348
<212> DNA
<213>People (Homo sapiens)
<400> 2
atggactact accggaagta cgccgccatc ttcctggtga ccctgtccgt gttcctgcac 60
gtgctgcact ccgcccctga cgtgcaggac tgccctgagt gcaccctgca ggagaacccc 120
ttcttctccc agcccggagc ccctatcctg cagtgcatgg gctgctgctt ctccagggcc 180
taccctaccc ccctgaggag caagaagacc atgctggtgc agaagaacgt gacctccgag 240
agcacctgct gcgtggccaa gtcctacaac agggtgaccg tgatgggcgg cttcaaggtg 300
gagaaccaca ccgcctgcca ctgctccacc tgctactacc acaagtcc 348
<210> 3
<211> 165
<212> PRT
<213>People (Homo sapiens)
<400> 3
Met Glu Met Phe Gln Gly Leu Leu Leu Leu Leu Leu Leu Ser Met Gly
1 5 10 15
Gly Thr Trp Ala Ser Lys Glu Pro Leu Arg Pro Arg Cys Arg Pro Ile
20 25 30
Asn Ala Thr Leu Ala Val Glu Lys Glu Gly Cys Pro Val Cys Ile Thr
35 40 45
Val Asn Thr Thr Ile Cys Ala Gly Tyr Cys Pro Thr Met Thr Arg Val
50 55 60
Leu Gln Gly Val Leu Pro Ala Leu Pro Gln Val Val Cys Asn Tyr Arg
65 70 75 80
Asp Val Arg Phe Glu Ser Ile Arg Leu Pro Gly Cys Pro Arg Gly Val
85 90 95
Asn Pro Val Val Ser Tyr Ala Val Ala Leu Ser Cys Gln Cys Ala Leu
100 105 110
Cys Arg Arg Ser Thr Thr Asp Cys Gly Gly Pro Lys Asp His Pro Leu
115 120 125
Thr Cys Asp Asp Pro Arg Phe Gln Asp Ser Ser Ser Ser Lys Ala Pro
130 135 140
Pro Pro Ser Leu Pro Ser Pro Ser Arg Leu Pro Gly Pro Ser Asp Thr
145 150 155 160
Pro Ile Leu Pro Gln
165
<210> 4
<211> 495
<212> DNA
<213>People (Homo sapiens)
<400> 4
atggagatgt tccagggcct gctgctgctc ctgctgctca gcatgggcgg cacatgggcc 60
tccaaggagc ctctcaggcc caggtgcagg cctatcaacg ccaccctggc cgtggagaag 120
gaaggatgcc ccgtgtgcat caccgtgaac accaccatct gcgccggcta ctgccccaca 180
atgaccaggg tgctgcaagg agtgctgcct gccctgcccc aagtggtgtg caactaccgg 240
gacgtgaggt tcgagtccat caggctgcct ggctgcccta ggggagtcaa ccctgtggtc 300
tcctacgccg tggccctgtc ctgtcagtgt gccctgtgca ggcggtccac aacagactgc 360
ggcggaccca aggaccaccc tctgacctgc gacgacccca ggttccaaga ctcctcctcc 420
tccaaggctc cccctccttc cctcccttcc cctagcaggc tgcctggacc ttccgacacc 480
cccattctgc cccag 495
Claims (10)
1. recombinate the preparation method of chorionic gonadotrophin rhCG, which is characterized in that express and recombinate using mammal eukaryotic expression system
Chorionic gonadotrophin rhCG;The recombination chorionic gonadotrophin rhCG includes α and β subunits, and the two is connected by Van der Waals force;
Wherein, the α subunits:
I) by SEQ ID NO:The albumen that amino acid sequence shown in 1 is formed;Or
ii)SEQ ID NO:Amino acid sequence shown in 1 is substituted, lacks and ors add one or several amino acid and equal work(
The albumen as derived from i) of energy;Or
Iii) with SEQ ID NO:Amino acid sequence homology shown in 1 is more than 90%, and the amino acid with equal function
The albumen of Sequence composition;
The β subunits:
I) by SEQ ID NO:The albumen that amino acid sequence shown in 3 is formed;Or
ii)SEQ ID NO:Amino acid sequence shown in 3 is substituted, lacks and ors add one or several amino acid and equal work(
The albumen as derived from i) of energy;Or
Iii) with SEQ ID NO:Amino acid sequence homology shown in 3 is more than 90%, and the amino acid with equal function
The albumen of Sequence composition.
2. according to the method described in claim 1, it is characterized in that, according to NCBI announce hCG α and β subunits gene order,
Gene order optimization is carried out according to mammalian codons preferences, the gene order of the α and β subunits after optimization is implemented in respectively
Different expression cassettes is then attached on same expression vector, converts host cell, and expressed in host cell, and separation is pure
Change target protein;Alternatively,
The gene order of α and β subunits after optimization is building up on expression vector respectively, gained recombinant vector cotransformation host
Cell, and expressed in host cell, isolate and purify target protein;
Wherein, the gene order of the α and β subunits after optimization is respectively such as SEQ ID NO:Shown in 2 and 4.
3. according to the method described in claim 2, it is characterized in that, the expression vector is selected from pCG, pcDNA3.1, pMS2-
GFP, pCMV5, preferably pcDNA3.1.
4. according to the method described in claim 2, it is characterized in that, the host cell CHO or 293 cells.
5. following any application of recombination chorionic gonadotrophin rhCG prepared by any one of claim 1-4 the methods:
1) promote the application in animal reproduction;
2) application in the medicine preparation for the treatment of animals' reproduction relevant disease;
3) application in ocyodinic is prepared.
6. application according to claim 5, which is characterized in that the animal is mammal or fish;Wherein, the food in one's mouth
Newborn animal is pig, ox, sheep, horse or dog;The fish are fresh water or marine fishes, preferably freshwater fish.
7. application according to claim 6, which is characterized in that it is described promotion animal reproduction refer to promote egg mother cell into
It is ripe, promote estrus synchronization, superfecundation, induced breeding.
8. the method that fish are hastened parturition, which is characterized in that hastened parturition by injecting ocyodinic to fish;Wherein, the ocyodinic
Active constituent at least containing any one of claim 1-4 the methods prepare recombination chorionic gonadotrophin rhCG;
The preferred freshwater fish of fish, including four large Chinese carps, Cypriniformes, Perciformes, Silurformes, salmon shape mesh, Gadiformes, Pacific herring shape
The economic fish of mesh and Gadiformes, the economic fish of more preferable Cypriniformes, Perciformes and Silurformes.
9. according to the method described in claim 8, it is characterized in that, the injection dosage of rhCG is 200-2000IU/kg weight.
10. according to the method described in claim 8, it is characterized in that, hastened parturition using two needle injections, the ocyodinic injected for the first time
For LRH-A, injection dosage is 1-2 μ g/kg weight;Second of injection is carried out after injecting 10-12h for the first time, second of injection is urged
It is LRH-A 2-10 μ g/kg weight, DOM 5-6 μ g/kg weight and rhCG 400-600IU/kg weight to produce agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810271691.7A CN108264549A (en) | 2018-03-29 | 2018-03-29 | Recombinate the preparation method and application of chorionic gonadotrophin rhCG |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810271691.7A CN108264549A (en) | 2018-03-29 | 2018-03-29 | Recombinate the preparation method and application of chorionic gonadotrophin rhCG |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108264549A true CN108264549A (en) | 2018-07-10 |
Family
ID=62778030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810271691.7A Pending CN108264549A (en) | 2018-03-29 | 2018-03-29 | Recombinate the preparation method and application of chorionic gonadotrophin rhCG |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108264549A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114349844A (en) * | 2021-12-29 | 2022-04-15 | 北京伟杰信生物科技有限公司 | Purification method of recombinant chorionic gonadotrophin for livestock |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767251A (en) * | 1983-11-02 | 1998-06-16 | Genzyme Corporation | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
CN102549011A (en) * | 2009-10-05 | 2012-07-04 | 辉凌公司 | Pharmaceutical preparation comprising recombinant HCG |
CN103539862A (en) * | 2013-11-01 | 2014-01-29 | 广州优联康医药科技有限公司 | Long-acting recombinant follicle-stimulating hormone and application thereof |
CN103804498A (en) * | 2013-11-29 | 2014-05-21 | 广州诺新生物技术有限公司 | Controlled release recombinant chorionic gonadotrophin and application thereof |
CN107532172A (en) * | 2015-04-24 | 2018-01-02 | 辉凌公司 | The method for producing promoting sexual gland hormone |
-
2018
- 2018-03-29 CN CN201810271691.7A patent/CN108264549A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767251A (en) * | 1983-11-02 | 1998-06-16 | Genzyme Corporation | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
CN102549011A (en) * | 2009-10-05 | 2012-07-04 | 辉凌公司 | Pharmaceutical preparation comprising recombinant HCG |
CN103539862A (en) * | 2013-11-01 | 2014-01-29 | 广州优联康医药科技有限公司 | Long-acting recombinant follicle-stimulating hormone and application thereof |
CN103804498A (en) * | 2013-11-29 | 2014-05-21 | 广州诺新生物技术有限公司 | Controlled release recombinant chorionic gonadotrophin and application thereof |
CN107532172A (en) * | 2015-04-24 | 2018-01-02 | 辉凌公司 | The method for producing promoting sexual gland hormone |
Non-Patent Citations (4)
Title |
---|
SUNG N等: "choriogonadotropin subunit beta 3 precursor [Homo sapiens]", 《GENBANK DATABASE》 * |
WANG H等: "glycoprotein hormones alpha chain isoform 2 precursor [Homo sapiens]", 《GENBANK DATABASE》 * |
刘扬: "CHO细胞表达重组人绒毛膜促性腺激素性腺激素的调控机理研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
王鸿利,叶裕春主编: "《中华检验医学大辞典》", 31 October 2000, 上海科学技术出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114349844A (en) * | 2021-12-29 | 2022-04-15 | 北京伟杰信生物科技有限公司 | Purification method of recombinant chorionic gonadotrophin for livestock |
CN114349844B (en) * | 2021-12-29 | 2024-02-13 | 北京伟杰信生物科技有限公司 | Purification method of recombinant chorionic gonadotrophin for livestock |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Eales | Iodine metabolism and thyroid-related functions in organisms lacking thyroid follicles: are thyroid hormones also vitamins? | |
CN100431408C (en) | Method for breeding two hybrid species of fish | |
Mollah et al. | HCG-induced spawning of the catfish, Clarias macrocephalus (Gunther) | |
CN104206323B (en) | A kind of Chinese snake head hatching method | |
CN104365513B (en) | A kind of Silurus asotus fish genus cross breeding method | |
CN110352877B (en) | All-season artificial propagation method for micropterus salmoides | |
CN101182360B (en) | Fusion protein having antibiotic function and uses thereof | |
CN106172136B (en) | A kind of fugu obscurus winter artificial fecundation method | |
CN105766732A (en) | Artificial reproduction method of mandarin fish | |
CN103493767B (en) | Odontobulis mpotamophila and Odontobutis yaluensis cross breeding method | |
CN103875567A (en) | Artificial spawning method for osteoglossum bicirrhosum | |
CN102715115A (en) | Phoxinus lagowskii fry breeding method | |
CN108264549A (en) | Recombinate the preparation method and application of chorionic gonadotrophin rhCG | |
CN105766731A (en) | Low-cost propagation method of bass | |
CN107155971A (en) | Yi Zhong Gan fishes and black carp quasi aromatic hybrid rice breeding method | |
CN104488787B (en) | A kind of propagation method of Coregonus ussuriensis fry | |
Wiegand et al. | Effects of rearing temperature on development and survival of embryonic and larval goldfish | |
CN105010236A (en) | Breeding raising method for meat sheep | |
CN110178766B (en) | Artificial breeding method of Acipenser lapipenser | |
CN106577376A (en) | Hybrid gurnard fry breeding technology | |
CN114885865A (en) | Spawning induction method suitable for female silurus riparia | |
CN114467808A (en) | Large-scale preparation method of bighead carp grown from distant hybridization natural gynogenesis | |
CN106172124A (en) | A kind of artificial breeding method of Europe, southern area huso sturgeon | |
Karim et al. | Hormone induced artificial breeding of a commercially important marine finfish, striped mullet (Mugil cephalus L.) in Bangladesh | |
CN109699530A (en) | Loach breeding induced spawning method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180710 |